Among them, SUZ12 is considered an important oncogene involved in several cancers such as bladder cancer, non‐small cell lung cancer, and ovarian cancer, and is currently a research hotspot in targeted therapy for various types of tumours [16, 17, 18]. This evidence concerns the gene SUZ12 and ovarian cancer.